The LJWG 2014 conference is funded through educational grants from AbbVie Ltd, Gilead Sciences Ltd and MSD Ltd and sponsored by Bristol-Myers Squibb. None.

Slides:

Advertisements

Similar presentations

Mental Health Strategy Event Clinical Commissioning Groups Dr Chris Harris GP – The Ridge Chair – GPCE Clinical Director, Partnerships & Health Inequalities,

Advertisements

West Midlands Academic Health Science Network

Public Health Workforce Development

Engaging with the NHS Commissioning Board and the impact of the changes in the wider LHE Simon Weldon, NHS Commissioning Board London Regional Team London.

West Sussex Health and Wellbeing Board

DRAFT, IN PREPARATION Regional Voices for Better Health Dr Paul Plant Deputy Director Health Improvement Public Health England (London Region)

Understanding the pathway: barriers to data collection and onward referral to specialist hepatitis C services for PWUD in London.

Informatics priorities and strategy Chris Carrigan Deputy to the PHE Chief Knowledge Officer, Information Services.

‘Over view of Public Health England in Greater Manchester’

Local Education and Training Boards Adam C Wardle Managing Director, Yorkshire and the Humber Local Education and Training Board.

Representing Central Government in the South East Monday, 27 April 2015 Vivien Lines DCSF Safeguarding Adviser VCS Safeguarding Seminar 17 December 2009.

Claire Munro Co-facilitator London Joint Working Group on Substance Use and Hepatitis C The role of technology in supporting patient pathways.

NHS Services, Seven Days a Week Professor Sir Bruce Keogh National Medical Director NHS England.

North West London Month 12 Budget Update SaHF & NWL Strategy and Transformation Programmes April 2014.

Reducing blockages in the pathway to Hepatitis C treatment Emma Burke, PHE.

Public Service Transformation: what’s working and what’s not? Speaker: Sir Derek Myers, co-chair of the independent service transformation panel Robert.

Improving the Health and Wellbeing of People with Learning Disabilities: An Evidence-Based Commissioning Guide for Clinical Commissioning Groups Dr Matt.

1 A consistent approach to personalised care Designing for care Dr Paul Whatling Senior Clinical Consultant.

Kent Health Commission “The Art of the Possible” Grasping the opportunity of the health and social care reforms 17 November 2011.

Health and Wellbeing in Derby Derek Ward Joint Director of Public Health.

North West Coast Patient Safety Collaborative Presented by: Aly Hulme Associate Director.

South Gloucestershire CCG’s Commissioning Priorities

North West London LETB Board – 1 st meeting 12 Nov November Purpose: To plan and commission education & training to ensure a highly skilled and appropriate.

Improving the Health and Wellbeing of People with Learning Disabilities: An Evidence-Based Commissioning Guide for Clinical Commissioning Groups Dr Matt.

Designing a culturally appropriate self-management intervention for primary breast cancer patients from different ethnic groups using ‘Experience Based.

Proposed NWL LETB Governance Care Pathway 1 Care Pathway 2 Care Pathway 3 NWL LETB Board Stakeholder Advisory Group Professional Groups Health Education.

West London Mental Health NHS Trust CQC Action Plan Response to Recommendations Nigel McCorkell - Chairman Peter Cubbon – Chief Executive Ian Kent – Deputy.

Integration Working together for a caring, healthier, safer Edinburgh 12 th February 2012.

South East Mental Health Commissioning Network Tuesday 19 th November 2013 Holiday Inn, Egerton Road, Guildford, Surrey Supported through an unrestricted.

Darzi Review and The End of Life Care Strategy A summary and initial analysis Graham Elderfield Chief Executive Earl Mountbatten Hospice

RCGP training online: new training in short bites Danny Morris, Expert Lead RCGP Hepatitis B and C Part 1.

Long Term Conditions Overview Tuesday, 22 May 2007 Dr Bill Mutch.

Click to edit Master title style Click to edit Master subtitle style Risks and Opportunities in the new Public Health System Dympna Edwards Deputy Regional.

GRAND Getting Real about Alcohol ‘N’ Drugs Community responses to alcohol and drug issues ADP Communities Sub-group Presentation to Community Council’s.

NHSCB Focus on Commissioning the Information Centre Presented by Cathy Hassell Supplier Event / 31 May 2012.

Working With Health And Developing the Local Offer Council for Disabled Children, May 2014.

The New Public Health System

NHS Reforms – what does it mean for the Nottinghamshire Children’s Trust? Dr Kate Allen – Consultant in Public Health Medicine Irene Kakoullis – Head of.

Wessex LETB The Changing Landscape Paul Holmes, Managing Director.

Penny Emerit Acting Director of London Programmes May 2010 Polysystems: how do they support tackling health inequalities in Sectors and PCTs?

Organisational Journey Supporting self-management

Richmond Clinical Commissioning Group Annual General Meeting 22 September 2015.

Dr Ashley Brown Consultant Hepatologist, St. Mary’s and Hammersmith Hospitals, London and Honorary Senior Lecturer, Imperial College London The Updated.

David Badcock Head of Recovery Engagement - Addaction The role of drug treatment providers in the care pathway: practical learning from the South West.

Health and Wellbeing: JSNA, Strategy, Outcomes Chris Kenny Director of Public Health.

Transforming Patient Experience: The essential guide

National Mental Health, Dementia and Neurology Intelligence Network (NMHDNIN) James Seward, Programme Lead.

Policy landscape and integration Commissioning, Procurement, SDS and Markets – where should we be heading? 8 October 2014 – Afternoon Session Joint Improvement.

#LJWG2015 HEPATITIS C IN PEOPLE WHO USE DRUGS Improving Care for Hepatitis C: A Framework Approach LONDON 2015.

Formal agreement between the CCG, City Council, Salford Royal and Greater Manchester West –Pooled health & social care budget and financial risk share.

Health Reforms The NHS White Paper Equity and Excellence: Liberating the NHS “…..one of the biggest shake-ups of the health system since the NHS was established”

Pilot workshops Alcohol Commissioning Learning Programme 21 & 22 September 2010, City University London.

#LJWG2015 HEPATITIS C IN PEOPLE WHO USE DRUGS Improving Care for Hepatitis C: A Framework Approach LONDON 2015.

NHS Reform Update October Context Health Reform Agenda Significant pace of change Clear focus on supporting the Transition Process At the same time.

R&D Annual Report SLaM Board, Sept 2004 Graham Thornicroft Gill Dale.

#LJWG2015 HEPATITIS C IN PEOPLE WHO USE DRUGS Improving Care for Hepatitis C: A Framework Approach LONDON 2015.

Hepatitis C policy development The Challenges The broad challenges General election No government liver strategy No clarity of who funds what No specific.

Co-Production in Tayside Paul Ballard Deputy Director of Public Health NHS Tayside Honorary Senior Lecturer Dundee University Medical School.

NHS reforms and impact on Pharmacy. Objective Update on the NHS reforms and Public Health and Education Landscapes Outline new structures, organisations.

Commissioning Weight Management Services Professor Jonathan Valabhji National Clinical Director for Obesity and Diabetes Berkshire Public Health Weight.

“Our vision is for a Scotland where people who are disabled or living with long term conditions and unpaid carers have a strong voice and enjoy their right.

Local Education and Training Boards Tim Gilpin Director of Workforce and Education NHS North of England.

Launch event Wednesday 13 March NHS South Worcestershire CCG LocalityPracticesPopulation Droitwich & Ombersley 534,379 Evesham, Bredon & Broadway.

Optimal Nutritional Care for All UK Update report In partnership with NHS England and the Malnutrition Taskforce With support from NHS Improvement Funded.

Glasgow City Council Social Work Services and Glasgow Providers Provider Event 25 November 2014 City Chambers.

Making Enfield an Autism Friendly Place

HEPATITIS C IN PEOPLE WHO USE DRUGS Improving Care for Hepatitis C: A Framework Approach LONDON 2015.

Developing a Community Peer Support model to improve access to HCV treatments for PWID. Lar Murphy,Ireland.

Central and North West London NHS Foundation Trust

Transforming Healthcare

Presentation transcript:

The LJWG 2014 conference is funded through educational grants from AbbVie Ltd, Gilead Sciences Ltd and MSD Ltd and sponsored by Bristol-Myers Squibb. None of the sponsors has had any control over the agenda or content.

Hepatitis C in London: practical steps to elimination Monday 17 th November 2014 Guildhall, London

Co-Chairs: Cllr Victoria Borwick Deputy Mayor of London Dr Ashley Brown Consultant Hepatologist, St. Mary’s and Hammersmith Hospitals London and Honorary Senior Lecturer, Imperial College London Hepatitis C in London: practical steps to elimination

#LJWG2014

SESSION 1 Tools to eliminate

Dr Helen Harris Clinical Scientist & Research Associate, Public Health England Tackling Hepatitis what PHE modelling shows us

Dee Cunniffe Policy Lead & Co-facilitator London Joint Working Group on Substance Use and Hepatitis C Data collection and barriers in the system

Professor Sharon Hutchinson Professor of Epidemiology & Population Health Glasgow Caledonian University Health Protection Scotland How aspirations can be built and levels of performance can be assured: learning from the Scottish Action Plan

Mike Burns CEO & Operations Director CAIR Scotland Needle exchange impact on hepatitis C pathways

Dr Magdalena Harris Qualitative Sociologist London School of Hygiene & Tropical Medicine Supporting people who use drugs and providers: Hep C info and care

Claire Munro Co-facilitator London Joint Working Group on Substance Use and Hepatitis C The role of technology in supporting patient pathways

Danny Morris RCGP Clinical Lead Hepatitis B & C, Part 1 certificate RCGP training online: new training in short bites

QUESTIONS Dr Ashley Brown Consultant Hepatologist, St. Mary’s and Hammersmith Hospitals, London and Honorary Senior Lecturer, Imperial College London Hepatitis C in London: practical steps to elimination

REFRESHMENT BREAK Hepatitis C in London: practical steps to elimination

SESSION 2 Collaborate to eliminate

Dr Éamonn O’Moore Head of Health & Justice Health & Wellbeing Directorate Public Health England Producing a framework for hepatitis C through partnership working

David Badcock Head of Recovery Engagement Addaction The role of drug treatment providers in the care pathway: practical learning from the South-West

Professor Matt Hickman Professor of Public Health & Epidemiology University of Bristol Reducing transmission in PWID by scaling up drug treatment, OST and needle exchange services

Dr Ashley Brown Consultant Hepatologist, St. Mary’s and Hammersmith Hospitals, London and Honorary Senior Lecturer, Imperial College London The Updated LJWG Consensus

QUESTIONS Cllr Victoria Borwick Deputy Mayor of London Hepatitis C in London: practical steps to elimination

WORKSHOPS Hepatitis C policy development - East Crypt (adjacent to Livery Hall) How to reduce blockages in the system by implementing care pathways in collaboration with commissioners - West Crypt (walk through the East Crypt) The impact of new drug treatments on elimination - Livery Hall (main plenary) Community mobilisation: engaging users to support needle exchanges and peer-led groups - City Marketing Suite Conference Room (outside and right)

LUNCH Hepatitis C in London: practical steps to elimination

The LJWG 2014 conference is funded through educational grants from AbbVie Ltd, Gilead Sciences Ltd and MSD Ltd and sponsored by Bristol-Myers Squibb. None of the sponsors has had any control over the agenda or content.

Hepatitis C in London: practical steps to elimination WORKSHOP FEEDBACK Chair: Charles Gore President, World Hepatitis Alliance Chief Executive, Hepatitis C Trust

Dr Suman Verma Institute of Liver Studies King's College Hospital London The impact of new drugs on elimination

New Drugs for HCV - key messages A tornado of new drugs Combinations of drugs together work best Less role of interferon 8-12 weeks duration Real life is not as per the trials Access & affordability The future is bright but the timelines unclear…

Chris Kelly Assistant Head of Health & Justice Commissioning NHS England Hepatitis C policy development

Solutions to policy challenges Chris Kelly, NHS England 1. Low public and GP awareness – education programmes, campaigns, training 2. Policy deprioritisation – overarching policy initiatives eg Health Check, Outcomes Framework 3. Inflexible services/time pressures – care navigators, community prescribing, digital access to information 4. Opaque commissioning – clearer guidance, ensuring strategies in place for longer than duration of tenders, focusing on service delivery and integration

Emma Burke Alcohol & Drugs Programme Manager Public Health England How to reduce blockages in the system by implementing care pathways in collaboration with commissioners

Reducing blockages in the pathway Blockages: Lack of understanding commissioning & where the funding comes from No recourse to public funds Treatment too difficult to access Tension between local and national priorities Short-term planning and commissioning Skills and education all along the pathway (staff and service users, commissioners) Solutions: Clarify role of CCGs, NHSE & Local Authorities, and funding for new treatments London-wide Commissioning and pathways Deliver treatment ‘near the service user’ / in the community / possibly by pharmacist Need a national driver and long-term plans Education and formal training Build Peer-support and user voice

Mat Southwell Partner Coact Community mobilisation: engaging users to support needle exchanges and peer-led groups

Community Mobilisation Engaging people who use drugs to support needle exchanges & peer led groups Mat Southwell Partner Coact

Community mobilisation NSPs Peer led NSPs Meaningful participation in traditional NSPs Secondary needle exchange Supplier engagement

Final panel Mike Burns CEO & Operations Director, CAIR Scotland Jim Conneely Hepatitis C Patient and Hepatitis C Trust outreach worker Professor Graham Foster Professor of Hepatology and Consultant Hepatologist, Bart’s and The Royal London Hospitals, London Professor Matt Hickman Professor of Public Health and Epidemiology, University of Bristol Peter Kohn Director, London Office of Clinical Commissioning Groups Dr Éamonn O’Moore Head of Health & Justice, Health & Wellbeing Directorate, Public Health England Dr Sally Porter Consultant in Addiction Psychiatry, South London and Maudsley NHS Foundation Trust, and Turning Point

The LJWG 2014 conference is funded through educational grants from AbbVie Ltd, Gilead Sciences Ltd and MSD Ltd and sponsored by Bristol-Myers Squibb. None of the sponsors has had any control over the agenda or content.